GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0000002
|
BP
|
mitochondrial genome maintenance
|
The maintenance of the structure and integrity of the mitochondrial genome; includes replication and segregation of the mitochondrial chromosome.
|
OPA1,
SLC25A4,
MPV17,
MEF2A,
SLC25A36,
MGME1,
PIF1,
MRPL17,
AKT3
|
GO:0000012
|
BP
|
single strand break repair
|
The repair of single strand breaks in DNA. Repair of such breaks is mediated by the same enzyme systems as are used in base excision repair.
|
TDP1
|
GO:0000018
|
BP
|
regulation of DNA recombination
|
Any process that modulates the frequency, rate or extent of DNA recombination, a DNA metabolic process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents.
|
IL7R,
KPNA2,
KPNA1,
ALYREF,
SMARCAD1
|
GO:0000019
|
BP
|
regulation of mitotic recombination
|
Any process that modulates the frequency, rate or extent of DNA recombination during mitosis.
|
MRE11A,
RAD50
|
GO:0000022
|
BP
|
mitotic spindle elongation
|
The cell cycle process in which the distance is lengthened between poles of the mitotic spindle. Mitotic spindle elongation begins during mitotic prophase and ends during mitotic anaphase B.
|
PRC1,
KIF23
|
GO:0000023
|
BP
|
maltose metabolic process
|
The chemical reactions and pathways involving the disaccharide maltose (4-O-alpha-D-glucopyranosyl-D-glucopyranose), an intermediate in the catabolism of glycogen and starch.
|
MGAM,
GAA
|
GO:0000027
|
BP
|
ribosomal large subunit assembly
|
The aggregation, arrangement and bonding together of constituent RNAs and proteins to form the large ribosomal subunit.
|
RPL10,
RPL12,
RPL5,
RPL23A,
RPL11,
RPL24,
MDN1,
MRTO4
|
GO:0000028
|
BP
|
ribosomal small subunit assembly
|
The aggregation, arrangement and bonding together of constituent RNAs and proteins to form the small ribosomal subunit.
|
RPS17,
RPSA,
RPS27,
RPS5,
RPS10,
RPS14,
RPS27L,
RRP7A
|
GO:0000038
|
BP
|
very long-chain fatty acid metabolic process
|
The chemical reactions and pathways involving a fatty acid which has a chain length greater than C22.
|
HSD17B4,
ACOX1,
ACOT4,
SLC27A6
|
GO:0000042
|
BP
|
protein targeting to Golgi
|
The process of directing proteins towards the Golgi; usually uses signals contained within the protein.
|
GOLGA4,
TRIP11,
SORL1,
GOLGA1,
OPTN
|
GO:0000045
|
BP
|
autophagosome assembly
|
The formation of a double membrane-bounded structure, the autophagosome, that occurs when a specialized membrane sac, called the isolation membrane, starts to enclose a portion of the cytoplasm.
|
ATG13,
ATG12,
PSEN1,
GABARAPL2,
RAB1A,
WIPI1,
KIAA1324,
TP53INP2,
ATG16L2,
RB1CC1,
TP53INP1,
ATG2B,
MAP1LC3B,
GABARAPL1,
MAP1LC3A,
RAB23,
WDR45,
WIPI2
|
GO:0000050
|
BP
|
urea cycle
|
The sequence of reactions by which arginine is synthesized from ornithine, then cleaved to yield urea and regenerate ornithine. The overall reaction equation is NH3 + CO2 + aspartate + 3 ATP + 2 H2O = urea + fumarate + 2 ADP + 2 phosphate + AMP + diphosphate.
|
ASS1,
CAD,
SLC25A15
|
GO:0000052
|
BP
|
citrulline metabolic process
|
The chemical reactions and pathways involving citrulline, N5-carbamoyl-L-ornithine, an alpha amino acid not found in proteins.
|
DDAH1,
DDAH2,
ASS1
|
GO:0000053
|
BP
|
argininosuccinate metabolic process
|
The chemical reactions and pathways involving argininosuccinate, 2-(N(omega)-arginino)succinate, an intermediate in the ornithine-urea cycle, where it is synthesized from citrulline and aspartate.
|
ASS1
|
GO:0000054
|
BP
|
ribosomal subunit export from nucleus
|
The directed movement of a ribosomal subunit from the nucleus into the cytoplasm.
|
EIF6,
ABCE1
|
GO:0000055
|
BP
|
ribosomal large subunit export from nucleus
|
The directed movement of a ribosomal large subunit from the nucleus into the cytoplasm.
|
XPO1,
RRS1,
NUP88,
SDAD1
|
GO:0000056
|
BP
|
ribosomal small subunit export from nucleus
|
The directed movement of a ribosomal small subunit from the nucleus into the cytoplasm.
|
XPO1,
NUP88
|
GO:0000059
|
BP
|
protein import into nucleus, docking
|
A protein complex assembly process that contributes to protein import into the nucleus, and that results in the association of a cargo protein, a carrier protein such as an importin alpha/beta heterodimer, and a nucleoporin located at the periphery of the nuclear pore complex.
|
IPO5,
TNPO2,
RANBP6,
KPNB1,
IPO4,
NUP205
|
GO:0000060
|
BP
|
protein import into nucleus, translocation
|
A protein transport process that contributes to protein import into the nucleus, and that results in the vectorial transfer of a cargo-carrier protein complex through the nuclear pore complex from the cytoplasmic side to the nucleoplasmic side of the nuclear envelope.
|
IPO5,
TNPO2,
RANBP6,
TGFB1,
TNF,
BCL3,
MT3,
AKT1,
BCL6,
AKR1C3,
SLC11A1,
NUTF2,
POLA2,
KPNB1,
CEP57,
IPO4,
PHB2,
RBM22
|
GO:0000066
|
BP
|
mitochondrial ornithine transport
|
The directed movement of ornithine, 2,5-diaminopentanoic acid, into, out of or within a mitochondrion.
|
SLC25A15
|
GO:0000070
|
BP
|
mitotic sister chromatid segregation
|
The cell cycle process in which replicated homologous chromosomes are organized and then physically separated and apportioned to two sets during the mitotic cell cycle. Each replicated chromosome, composed of two sister chromatids, aligns at the cell equator, paired with its homologous partner. One homolog of each morphologic type goes into each of the resulting chromosome sets.
|
NDC80,
ZNF207,
BUB3,
ZWINT,
CENPA,
NEK2,
PLK1,
MAD2L1,
ESPL1,
SMC1A,
CEP57,
KIF18B,
SPAG5,
KIFC1,
NUSAP1,
DSN1,
SMC4,
KNSTRN
|
GO:0000075
|
BP
|
cell cycle checkpoint
|
A cell cycle process that controls cell cycle progression by monitoring the integrity of specific cell cycle events. A cell cycle checkpoint begins with detection of deficiencies or defects and ends with signal transduction.
|
FANCG,
CCNE2,
RB1,
CCNG2,
ZAK
|
GO:0000076
|
BP
|
DNA replication checkpoint
|
A cell cycle checkpoint that prevents the initiation of nuclear division until DNA replication is complete, thereby ensuring that progeny inherit a full complement of the genome.
|
DNA2,
RAD9B,
RAD9A,
CDC6,
TIPIN,
CDT1
|
GO:0000077
|
BP
|
DNA damage checkpoint
|
A cell cycle checkpoint that regulates progression through the cell cycle in response to DNA damage. A DNA damage checkpoint may blocks cell cycle progression (in G1, G2 or metaphase) or slow the rate at which S phase proceeds.
|
CHEK1,
RAD1,
NBN,
H2AFX,
E2F1,
PTPN11,
PEA15,
MAPK14,
ATRIP,
USP28,
RAD9A,
RHNO1,
INTS7,
ZAK
|
GO:0000079
|
BP
|
regulation of cyclin-dependent protein serine/threonine kinase activity
|
Any process that modulates the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity.
|
CCNT1,
CCNT2,
DIRAS3,
CCNE2,
CCNA2,
GADD45A,
CDC25A,
CDC25C,
SFN,
GTF2H1,
CDKN1A,
CDKN2B,
CDKN2C,
CDKN1B,
CDK7,
CCNG1,
BLM,
PTEN,
CDC37,
CDKN3,
PKMYT1,
CDC6,
BCCIP
|
GO:0000082
|
BP
|
G1/S transition of mitotic cell cycle
|
The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated.
|
CDC7,
PPP6C,
ORC5,
LATS1,
CCNE2,
DHFR,
TYMS,
ITGB1,
RB1,
CDK1,
EIF4E,
INHBA,
POLA1,
CDK4,
PCNA,
GSPT1,
RCC1,
CDK2,
MCM3,
CDC25A,
RRM2,
MCM4,
MCM5,
MCM7,
RPA3,
ACVR1B,
CDKN1A,
CDKN2C,
RANBP1,
CDKN1B,
ID4,
CDC34,
PRIM1,
PRIM2,
MCM2,
CDK7,
BCAT1,
POLE2,
RPS6,
CCNA1,
CDK3,
CDK6,
ACVR1,
PPAT,
POLE,
PPP3CA,
SKP2,
ORC1,
EIF4EBP1,
CAMK2D,
CUL2,
CUL3,
CUL4A,
POLA2,
MCM6,
CDKN3,
RHOU,
MCM10,
IQGAP3,
CACUL1,
CRLF3,
CUL5,
CDCA5,
PKMYT1,
CDC6,
CDT1,
LATS2,
PLK2,
ORC3,
DBF4,
MCM8,
FBXO5,
ORC6
|
GO:0000083
|
BP
|
regulation of transcription involved in G1/S transition of mitotic cell cycle
|
Any process that regulates transcription such that the target genes are involved in the transition between G1 and S phase of the mitotic cell cycle.
|
BACH1,
BRD4,
DHFR,
TYMS,
RB1,
CDK1,
POLA1,
PCNA,
RRM2,
CCNA1,
ORC1,
NPAT,
CDC6,
CDT1,
FBXO5
|
GO:0000086
|
BP
|
G2/M transition of mitotic cell cycle
|
The mitotic cell cycle transition by which a cell in G2 commits to M phase. The process begins when the kinase activity of M cyclin/CDK complex reaches a threshold high enough for the cell cycle to proceed. This is accomplished by activating a positive feedback loop that results in the accumulation of unphosphorylated and active M cyclin/CDK complex.
|
PLK4,
CHEK1,
AURKA,
PPP1R12A,
ENSA,
SSNA1,
PPP1R12B,
HMMR,
OFD1,
HAUS5,
CEP152,
CCNB2,
PCNT,
LATS1,
TUBB4A,
CDK1,
TUBB,
HSP90AA1,
UBC,
CCNB1,
PRKACA,
TUBG1,
CDK2,
PPP2R1A,
WEE1,
CDC25A,
CDC25B,
CDC25C,
PRKAR2B,
CDKN1A,
CDKN2B,
NES,
CSNK1D,
CSNK1E,
CDK7,
NEK2,
PLK1,
ARPP19,
PPP1CB,
CALM2,
YWHAE,
RPS27A,
UBA52,
DYNLL1,
SKP1,
TUBA4A,
TUBB4B,
KHDRBS1,
FOXM1,
SKP2,
DYNC1I2,
DCTN2,
CKAP5,
DCTN1,
DYNC1H1,
MELK,
PCM1,
MAPRE1,
TPD52L1,
ODF2,
CEP78,
CEP135,
BORA,
TUBA1A,
HAUS6,
SDCCAG8,
CEP57,
CEP70,
PHLDA1,
HAUS1,
OPTN,
MASTL,
AJUBA,
PKMYT1,
HAUS7,
FBXL15,
HAUS4,
CSRP2BP,
CENPJ,
PLCB1,
HAUS2,
NDE1,
FBXL7,
TPX2,
BTRC
|
GO:0000096
|
BP
|
sulfur amino acid metabolic process
|
The chemical reactions and pathways involving amino acids containing sulfur, comprising cysteine, homocysteine, methionine and selenocysteine.
|
AHCY,
GCLC,
GCLM,
MTR
|
GO:0000097
|
BP
|
sulfur amino acid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of amino acids containing sulfur, comprising cysteine, methionine and selenocysteine.
|
CDO1
|
GO:0000098
|
BP
|
sulfur amino acid catabolic process
|
The chemical reactions and pathways resulting in the breakdown of amino acids containing sulfur, comprising cysteine, methionine and selenocysteine.
|
CTH
|
GO:0000103
|
BP
|
sulfate assimilation
|
The pathways by which inorganic sulfate is processed and incorporated into sulfated compounds.
|
PAPSS2,
TXN,
TXN2
|
GO:0000105
|
BP
|
histidine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of histidine, 2-amino-3-(1H-imidazol-4-yl)propanoic acid.
|
MTHFD1,
MTHFD2L
|
GO:0000117
|
BP
|
regulation of transcription involved in G2/M transition of mitotic cell cycle
|
Any process that regulates transcription such that the target genes are transcribed as part of the G2/M transition of the mitotic cell cycle.
|
BACH1
|
GO:0000122
|
BP
|
negative regulation of transcription from RNA polymerase II promoter
|
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
E2F8,
CNOT1,
AHRR,
SUPT5H,
WWP2,
ZNF593,
ARID1A,
BHLHE40,
BACH1,
XPO1,
SMAD7,
MDM4,
HDAC3,
FOXP2,
PER1,
PAX4,
HOXA2,
KLF4,
FOXO3,
SNAI2,
TCF21,
SOX15,
PARK2,
ZEB2,
KDM1A,
SORBS3,
SHOX2,
TBL1X,
MITF,
SIN3B,
ZNF217,
H2AFY,
NCOR1,
MAF,
HSBP1,
USP2,
ZNF189,
PSMD10,
URI1,
DKK1,
TRIM37,
HEXIM1,
ZNF205,
ZBTB7A,
CBX7,
MBD3,
WHSC1,
MYC,
TGFB1,
PTH,
TNF,
ESR1,
TP53,
EDN1,
NFIC,
HMGB1,
PARP1,
UBC,
GLI2,
GLI3,
HIST1H1E,
NR2F1,
TXN,
FGFR1,
VDR,
ESRRA,
TPR,
BMP2,
BMP4,
SKI,
SKIL,
HCLS1,
ETS2,
EZR,
VEGFA,
HIVEP1,
TCF3,
GCFC2,
HIST1H1C,
CD36,
JUNB,
JUND,
TAL1,
DDX5,
EGR1,
ATF3,
WT1,
NFKB1,
FST,
NR1D1,
EFNA1,
FGFR2,
BMP6,
HNRNPA2B1,
SFPQ,
SP100,
NR2F2,
YY1,
DNMT1,
ZFP36,
CALR,
MZF1,
RBL1,
KDM5A,
FGF9,
CTNNB1,
PHB,
DDIT3,
SOX6,
SREBF1,
PPARG,
ZEB1,
SNCA,
IFI27,
STAT3,
ID1,
LEP,
BCL6,
NR4A2,
NKX2-1,
NOTCH1,
ID4,
RFX5,
NRIP1,
PSEN1,
CDKN1C,
ERF,
ASCL1,
SMARCA2,
SMARCA4,
NR0B1,
HDGF,
ZNF136,
HMGA2,
PLK1,
FOSB,
ATN1,
NR1H2,
HDAC4,
CTBP2,
FOXL2,
UBE2D3,
PKIA,
RPS14,
RPS27A,
UBA52,
UBE2I,
YBX1,
IGBP1,
BTG2,
HAMP,
SMAD3,
VLDLR,
HSF1,
MDM2,
E2F1,
INSM1,
RELB,
DR1,
SATB1,
POU5F1,
MEF2A,
ID2,
SP3,
ID3,
HHEX,
CAV1,
PPARD,
RELA,
TLE1,
REL,
MXD1,
ZBTB16,
MEF2C,
GABPA,
C1QBP,
DLX2,
PPARA,
FOXM1,
AES,
PPID,
EP300,
SREBF2,
FOXO1,
DLG1,
KLF10,
NR1H3,
MAP2K5,
GPS2,
TRIM28,
IKZF1,
NFATC2,
SMAD4,
SQSTM1,
HDAC1,
TDG,
CUL3,
PTCH1,
ACVR2B,
RUNX3,
CUX1,
SIM2,
HES1,
MXD4,
ZNF345,
ZNF268,
CHD4,
ARID5B,
DRAP1,
SUZ12,
TCEAL1,
ZMYND11,
ANKRD1,
NR0B2,
NCOA2,
TWIST1,
SMAD2,
EZH2,
ZFHX3,
CRY1,
NFIL3,
IFI16,
BRMS1L,
KANK2,
WWC2,
OTUD7B,
NIPBL,
ZNF280D,
ATF7IP,
NFXL1,
TSHZ1,
CXXC5,
MTDH,
JAZF1,
ZNF280B,
GATAD2A,
TMPRSS6,
MINA,
AEBP1,
WWC1,
SIRT2,
ZNF567,
NKAP,
EID2,
CPEB3,
GLIS3,
TRPV1,
FLCN,
SMARCC2,
OSR1,
ZNF564,
ZNF675,
FNIP1,
PPP1R13L,
HDAC7,
ZFPM2,
JDP2,
RTF1,
NR4A3,
ESR2,
HDAC2,
PROX1,
CREBBP,
N4BP2L2,
GATA6,
AURKB,
HES6,
AJUBA,
PAWR,
RITA1,
EHMT2,
PRMT6,
NEDD4L,
PURB,
PHF12,
NR1H4,
CIC,
TRIB3,
ZNF382,
SPEN,
UHRF1,
TSC22D3,
MNT,
MDFI,
CITED2,
HOPX,
TCF25,
DUSP26,
HDAC8,
BACH2,
TBL1XR1,
FOXP3,
PEG3,
ZNF350,
BCL11A,
EPC1,
HIPK2,
TXNIP,
FZD8,
SUV39H2,
SOX17,
SUDS3,
SMURF2,
TRPV4,
TAF9B,
ZBTB20,
CHD8,
HMG20A,
HEYL,
TCF7L2,
KMT5A,
DLL4,
TSHZ2,
DUSP22,
RLIM,
DACT1,
LMCD1,
H2AFY2,
ZBTB4,
FNIP2,
RCOR3,
RERE,
IMPACT,
DNMT3B,
UXT,
MLX,
TRPS1,
DDX20,
DACH1,
MOSPD1,
HDAC9,
ZHX1,
WWC3,
YEATS2,
SUFU,
TIMELESS,
TRIM33,
DICER1,
HDAC5,
ZNF148,
PKIG,
NOC2L,
MTF2,
NFE2L3,
HEY1,
HCFC2,
NCOR2,
EID1
|
GO:0000132
|
BP
|
establishment of mitotic spindle orientation
|
A cell cycle process that sets the alignment of mitotic spindle relative to other cellular structures.
|
NDC80,
SPRY2,
SPRY1,
HTT,
CENPA,
DYNLT1,
GPSM2,
ARHGEF2,
SPDL1,
NDEL1,
NDE1
|
GO:0000154
|
BP
|
rRNA modification
|
The covalent alteration of one or more nucleotides within an rRNA molecule to produce an rRNA molecule with a sequence that differs from that coded genetically.
|
NOP56
|
GO:0000160
|
BP
|
phosphorelay signal transduction system
|
A conserved series of molecular signals found in prokaryotes and eukaryotes; involves autophosphorylation of a histidine kinase and the transfer of the phosphate group to an aspartate that then acts as a phospho-donor to response regulator proteins.
|
KCNH2
|
GO:0000165
|
BP
|
MAPK cascade
|
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
|
PSMD11,
PSMD12,
EREG,
MAPK13,
PSMD3,
RASA4,
JAK2,
PSMD10,
PAK3,
FGF18,
FGF19,
EGFR,
MYC,
NRAS,
KRAS,
PDGFB,
TGFB1,
INS,
TNF,
IL1B,
RAF1,
PDGFA,
ERBB2,
FYN,
FGF2,
PDGFRB,
UBC,
CCL3,
KIT,
FGFR1,
CCL2,
CCL5,
SCG2,
NCAM1,
PDGFRA,
PSMC3,
PSMB1,
EFNA1,
RASA1,
KITLG,
FGF7,
FGFR2,
ERBB3,
JAK1,
PSMA1,
PSMA2,
PSMA3,
PSMA4,
ZFP36,
MAPK3,
PSMB8,
PSMB9,
PSMB4,
PSMB5,
MAPK1,
PEBP1,
FGF9,
YWHAB,
BTC,
IRS1,
ACTN2,
PSMC2,
MAP2K2,
PSMB10,
PSMC4,
MAPKAPK2,
PSMB3,
PSMD7,
JAK3,
MAP2K6,
NDST1,
MAP3K7CL,
PSME3,
CALM2,
PSMC1,
PSMC6,
RBX1,
RPS27A,
UBA52,
GRB2,
DLG4,
SHC2,
SPTBN1,
IL5RA,
MEF2A,
NRG1,
MAP2K1,
TEK,
CAV1,
PTK2,
MEF2C,
ZFP36L1,
SOS1,
GRIN2A,
MAPK7,
PSMD2,
CAMK2D,
CUL3,
IL18,
RASA3,
MEF2D,
PSME4,
PEA15,
RASA2,
ERBB4,
ANGPT1,
SMAD1,
DUSP5,
DUSP6,
DUSP7,
SETX,
SPRED1,
PABPN1,
FRS2,
FGF13,
SYNGAP1,
HBEGF,
MAP3K5,
DUSP9,
SPTBN4,
TAOK3,
DOK5,
NLK,
KL,
LAMTOR3,
LAMTOR2,
IRS2,
MAP3K4
|
GO:0000183
|
BP
|
chromatin silencing at rDNA
|
Repression of transcription of ribosomal DNA by altering the structure of chromatin.
|
SMARCA5,
HIST1H4A,
HIST1H3D,
H3F3A,
SIRT2
|
GO:0000184
|
BP
|
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
|
The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins.
|
CTIF,
PARN,
RPLP1,
RPLP2,
RPLP0,
RPS17,
RPSA,
GSPT1,
RPS2,
RPL35A,
RPL7,
RPL17,
RPS4Y1,
RPL13,
RPL10,
RPL12,
PPP2R1A,
RPL22,
RPL4,
RPL13A,
RPS27,
RPL35,
RPL27A,
RPL5,
RPL21,
RPL28,
RPS9,
RPS5,
RPS10,
RPL29,
RPL34,
RPL14,
RPS20,
RPS3A,
RPL26,
RPL15,
RPL27,
RPL37A,
RPL37,
RPS7,
RPS8,
RPS15A,
RPS16,
RPS14,
RPS18,
RPS13,
RPS11,
RPL7A,
RPL23A,
RPS6,
RPS25,
RPS26,
RPL30,
RPL31,
RPL10A,
RPL32,
RPL11,
RPL41,
RPS27A,
UBA52,
RPL38,
RPS21,
RPL24,
RPL36A,
RPL19,
RPL18A,
RPL18,
NCBP1,
RNPS1,
DCP2,
SMG8,
UHMK1,
SMG1,
UPF3A,
UPF2,
PNRC2,
SMG5,
RPL36,
RBM8A
|
GO:0000185
|
BP
|
activation of MAPKKK activity
|
Any process that initiates the activity of the inactive enzyme MAP kinase kinase kinase (MAPKKK).
|
GADD45B,
GADD45G,
TNF,
GADD45A,
TAB1,
MAP4K3,
MAP4K5
|
GO:0000186
|
BP
|
activation of MAPKK activity
|
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
|
MAP3K13,
MAP3K7,
JAK2,
GADD45B,
EGFR,
NGF,
RAF1,
NTRK1,
GNAI2,
BMP4,
F2R,
ADORA1,
TGFBR1,
MAP3K8,
CRKL,
PSEN1,
MAP3K7CL,
RAP1A,
ADAM9,
RAPGEF1,
CARTPT,
MLK4,
FRS2,
MAP3K5,
ZAK,
LAMTOR3,
TAOK2,
KIDINS220,
LAMTOR2,
MAP3K4
|
GO:0000187
|
BP
|
activation of MAPK activity
|
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
|
TLR4,
IRAK2,
MAP3K7,
RIPK2,
PAK3,
TGFA,
TNF,
IL1B,
CD74,
IGF1,
INSR,
CDK1,
THBS1,
FGF2,
UBC,
SAA1,
KIT,
GHR,
BMP2,
TDGF1,
HGF,
EFNA1,
FPR1,
C5AR1,
MAPK3,
MAPK1,
ADORA2B,
ERP29,
MAP2K2,
CHRNA7,
WNT5A,
PIK3CB,
MAPKAPK2,
IRAK1,
MAP2K6,
CD81,
CXCR4,
RPS27A,
UBA52,
SHC2,
NRG1,
MAP2K1,
PTPN11,
MAP2K5,
PEA15,
TAB1,
MAPK14,
DUSP5,
DUSP6,
DUSP7,
AVPI1,
CSPG4,
IQGAP3,
MUC20,
TAB3,
FRS2,
DUSP9,
GHRL
|
GO:0000188
|
BP
|
inactivation of MAPK activity
|
Any process that terminates the activity of the active enzyme MAP kinase.
|
DUSP1,
PPP2R1A,
RGS3,
RGS4,
DUSP3,
CAV1,
DUSP2,
DUSP8,
GPS2,
DUSP5,
DUSP6,
DUSP7,
SPRED1,
DUSP18,
DUSP9,
DUSP16,
DUSP21,
DUSP22,
DUSP10
|
GO:0000189
|
BP
|
MAPK import into nucleus
|
The directed movement of a MAP kinase to the nucleus upon activation.
|
TPR,
MAPK3,
MAPK1
|
GO:0000209
|
BP
|
protein polyubiquitination
|
Addition of multiple ubiquitin groups to a protein, forming a ubiquitin chain.
|
TMEM129,
PSMD11,
PSMD12,
PSMD3,
SIAH2,
PARK2,
PSMD10,
UBR5,
UBE4B,
TNKS,
UBC,
BCL2,
PSMC3,
PSMB1,
PSMA1,
PSMA2,
PSMA3,
PSMA4,
PSMB8,
PSMB9,
PSMB4,
PSMB5,
TPP2,
PSMC2,
PSMB10,
PSMC4,
CDC34,
UBE2A,
PSMB3,
RNF144A,
PSMD7,
UBE2E1,
NPEPPS,
UBE2D3,
PSME3,
PSMC1,
PSMC6,
RBX1,
RPS27A,
UBA52,
UBE2B,
SKP1,
CBLB,
PSMD2,
SKP2,
PPIL2,
UBE2V1,
CUL3,
BLMH,
CBFB,
PSME4,
SHPRH,
UBE3C,
UBE2V2,
LONRF1,
MARCH8,
HECTD2,
FBXO31,
RNF19B,
RNF111,
RNF165,
RNF144B,
RBBP6,
HUWE1,
TRIM69,
SIAH1,
UBE2J2,
FBXO22,
MARCH1,
MYLIP,
MIB2,
NEDD4L,
RNF126,
TRIM6,
TNKS2,
SMURF2,
RC3H2,
RNF19A,
RLIM,
DTL,
RNF181,
KLHL42,
HDAC6,
RNF14,
MKRN1,
LNPEP,
AMFR,
PRPF19,
STUB1,
RNF24,
BTRC,
ARIH1,
RNF114
|
GO:0000212
|
BP
|
meiotic spindle organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the microtubule spindle during a meiotic cell cycle.
|
AURKA,
TUBG1,
MYH9,
ESPL1
|
GO:0000226
|
BP
|
microtubule cytoskeleton organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins.
|
EML1,
MID1,
DYNC1LI2,
OBSL1,
ZPR1,
VAMP4,
TACC1,
TACC2,
PCNT,
GAPDH,
CDK1,
CNP,
MAPT,
MAP2,
NEFH,
SON,
TUBG1,
WEE1,
ATXN3,
TUBA1B,
MAP1A,
PTK2,
CAMSAP2,
MAP7,
CUL7,
MAP7D1,
PHLDB2,
GAS2L3,
TTL,
ULK4,
MARK4,
DOCK7,
CCDC8,
EML4,
RNF19A,
MARK1,
CAMSAP3,
UXT,
TACC3
|
GO:0000244
|
BP
|
spliceosomal tri-snRNP complex assembly
|
The formation of a tri-snRNP complex containing U4 and U6 (or U4atac and U6atac) snRNAs and U5 snRNAs and associated proteins. This includes reannealing of U4 and U6 (or U4atac and U6atac) snRNAs released from previous rounds of splicing to reform the U4/U6 snRNP (or U4atac/U6atac snRNP) as well as the subsequent association of the U5 snRNP with the U4/U6 snRNP (or U4atac/U6atac snRNP) to form a tri-snRNP that is ready to reassemble into another spliceosome complex.
|
PRPF3,
SRSF10,
CD2BP2,
SART3,
PRPF31,
DDX20,
PRPF19
|
GO:0000245
|
BP
|
spliceosomal complex assembly
|
The aggregation, arrangement and bonding together of a spliceosomal complex, a ribonucleoprotein apparatus that catalyzes nuclear mRNA splicing via transesterification reactions.
|
GCFC2,
RBM5,
SNRPD1,
SNRPD2,
SNRPD3,
SRPK2,
SART3,
GEMIN6,
SCAF11,
CRNKL1,
PRPF19,
LSM4
|
GO:0000255
|
BP
|
allantoin metabolic process
|
The chemical reactions and pathways involving allantoin, (2,5-dioxo-4-imidazolidinyl)urea, an intermediate or end product of purine catabolism.
|
GHR,
STAT5A,
STAT5B
|
GO:0000266
|
BP
|
mitochondrial fission
|
The division of a mitochondrion within a cell to form two or more separate mitochondrial compartments.
|
PARK2,
OPA1,
MTFR1,
MTFR2,
MFF
|
GO:0000271
|
BP
|
polysaccharide biosynthetic process
|
The chemical reactions and pathways resulting in the formation of a polysaccharide, a polymer of many (typically more than 10) monosaccharide residues linked glycosidically.
|
NDST1,
GLT8D1
|
GO:0000272
|
BP
|
polysaccharide catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a polysaccharide, a polymer of many (typically more than 10) monosaccharide residues linked glycosidically.
|
CHIT1
|
GO:0000278
|
BP
|
mitotic cell cycle
|
Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent.
|
RRM1,
CDC25B,
CENPF,
NEK4,
CDH13,
CENPE,
CENPC,
PAK2,
FAM175B,
CENPW,
KIF18B,
CDC5L,
AZI2,
NUDT15,
STK24
|
GO:0000281
|
BP
|
mitotic cytokinesis
|
A cell cycle process that results in the division of the cytoplasm of a cell after mitosis, resulting in the separation of the original cell into two daughter cells.
|
KIF20A,
KIF4A,
STAMBP,
STMN1,
SON,
RASA1,
APC,
CENPA,
PLK1,
SPTBN1,
KIF23,
ANK3,
CUL7,
CEP55,
SNX33,
MITD1,
CKAP2,
SNX18,
NUSAP1,
RACGAP1,
CHMP4B,
ANLN,
SPAST,
SNX9
|
GO:0000288
|
BP
|
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
|
A major pathway of degradation of nuclear-transcribed mRNAs that proceeds through a series of ordered steps that includes poly(A) tail shortening and that can regulate mRNA stability.
|
POLR2D,
CNOT3,
ZFP36,
ZFP36L2,
ZFP36L1
|
GO:0000289
|
BP
|
nuclear-transcribed mRNA poly(A) tail shortening
|
Shortening of the poly(A) tail of a nuclear-transcribed mRNA from full length to an oligo(A) length.
|
CNOT1,
CNOT3,
PARN,
CNOT4,
EIF4E,
EIF4B,
ZFP36,
MLH1,
EIF4A1,
EIF4A2,
PAN3,
SAMD4B,
PAIP1,
CNOT7,
CNOT6,
SAMD4A
|
GO:0000290
|
BP
|
deadenylation-dependent decapping of nuclear-transcribed mRNA
|
Cleavage of the 5'-cap of a nuclear mRNA triggered by shortening of the poly(A) tail to below a minimum functional length.
|
PAN3,
DCP2,
CNOT7,
NOCT
|
GO:0000291
|
BP
|
nuclear-transcribed mRNA catabolic process, exonucleolytic
|
The chemical reactions and pathways resulting in the breakdown of the transcript body of a nuclear-transcribed mRNA that occurs when the ends are not protected by the 5'-cap or the 3'-poly(A) tail.
|
POLR2G
|
GO:0000301
|
BP
|
retrograde transport, vesicle recycling within Golgi
|
The retrograde movement of substances within the Golgi, mediated by COP I vesicles. Cis-Golgi vesicles are constantly moving forward through the Golgi stack by cisternal progression, eventually becoming trans-Golgi vesicles. They then selectively transport membrane and luminal proteins from the trans- to the medial-Golgi while leaving others behind in the trans-Golgi cisternae; similarly, they selectively move proteins from the medial- to the cis-Golgi.
|
CUX1
|
GO:0000302
|
BP
|
response to reactive oxygen species
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
|
CCS,
GSR,
APOE,
SOD2,
CYBB,
APOD,
GPX1,
P4HB,
SOD3,
GSTP1,
TXN,
GPX3,
PRDX6,
S100A7,
PRDX2,
CYCS,
PRDX1,
HYAL2,
TXNRD1,
GPX8,
ERO1A,
NOX5,
GPX7,
TXN2,
NOX4,
PPARGC1A
|
GO:0000303
|
BP
|
response to superoxide
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a superoxide stimulus. Superoxide is the anion, oxygen-, formed by addition of one electron to dioxygen (O2) or any compound containing the superoxide anion.
|
SOD2,
UCP2,
UCP3
|
GO:0000320
|
BP
|
re-entry into mitotic cell cycle
|
The resumption of the mitotic cell division cycle by cells that were in a quiescent or other non-dividing state.
|
CCNF,
GSK3B
|
GO:0000338
|
BP
|
protein deneddylation
|
The removal of a ubiquitin-like protein of the NEDD8 type from a protein.
|
TOR1A
|
GO:0000350
|
BP
|
generation of catalytic spliceosome for second transesterification step
|
Conformational rearrangement of the spliceosomal complex containing the RNA products from the 1st step of splicing to form the catalytic site for the second step of splicing.
|
PRPF18
|
GO:0000354
|
BP
|
cis assembly of pre-catalytic spliceosome
|
Assembly of a spliceosomal complex containing the intact pre-mRNA and all of the spliceosomal snRNPs. This occurs when the tri-snRNP associates with the pre-mRNA and associated snRNPs in an ATP-dependent manner.
|
DDX23
|
GO:0000375
|
BP
|
RNA splicing, via transesterification reactions
|
Splicing of RNA via a series of two transesterification reactions.
|
PRPF3,
SRSF10,
TRA2B,
SF3A3,
SRRM1,
KHSRP,
SNRNP40,
SCAF11,
DDX23
|
GO:0000380
|
BP
|
alternative mRNA splicing, via spliceosome
|
The process of generating multiple mRNA molecules from a given set of exons by differential use of exons from the primary transcript(s) to form multiple mature mRNAs that vary in their exon composition.
|
KDM1A,
PQBP1,
SFPQ,
PTBP1,
HNRNPM,
SRSF1,
SRSF6,
CDK13,
RBM17,
RSRC1,
ESRP2
|
GO:0000381
|
BP
|
regulation of alternative mRNA splicing, via spliceosome
|
Any process that modulates the frequency, rate or extent of alternative splicing of nuclear mRNAs.
|
SAP18,
RBFOX2,
HNRNPL,
DDX5,
PTBP1,
RBMX,
RBM25,
RBM5,
TRA2B,
SRSF2,
FMR1,
SRSF6,
WTAP,
RNPS1,
MBNL2,
UHMK1,
SREK1,
RBM4,
RBFOX1,
THRAP3,
RBM8A
|
GO:0000387
|
BP
|
spliceosomal snRNP assembly
|
The aggregation, arrangement and bonding together of one or more snRNA and multiple protein components to form a ribonucleoprotein complex that is involved in formation of the spliceosome.
|
SNRPC,
SNRPB,
GEMIN4,
SNRPF,
SNRPD1,
SNRPD2,
SNRPD3,
SART3,
GEMIN5,
GEMIN6,
RBM22,
GEMIN8,
DDX20,
LSM4
|
GO:0000389
|
BP
|
mRNA 3'-splice site recognition
|
Recognition of the intron 3'-splice site by components of the assembling U2- or U12-type spliceosome.
|
SF3A3
|
GO:0000395
|
BP
|
mRNA 5'-splice site recognition
|
Recognition of the intron 5'-splice site by components of the assembling spliceosome.
|
PSIP1,
SNRPC,
SRSF1,
PRPF39
|
GO:0000398
|
BP
|
mRNA splicing, via spliceosome
|
The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.
|
DDX39A,
POLR2D,
DHX15,
HNRNPR,
PRPF3,
PPIH,
PLRG1,
NUDT21,
DHX16,
SYNCRIP,
PRPF40A,
SRSF10,
CD2BP2,
LSM8,
HNRNPC,
SNRPA,
SNRPC,
HNRNPA1,
SNRPA1,
GTF2F2,
SNRPB,
HNRNPL,
DDX5,
POLR2E,
HNRNPA2B1,
POLR2A,
PTBP1,
POLR2B,
HNRNPH3,
HNRNPH1,
GTF2F1,
FUS,
POLR2I,
RBMX,
BUD31,
SKIV2L2,
PAPOLA,
NOVA1,
HNRNPA3,
HNRNPM,
POLR2J,
RBM5,
POLR2K,
SNU13,
HNRNPH2,
SNRPF,
LSM3,
LSM6,
SNRPD1,
SNRPD2,
SNRPD3,
POLR2G,
POLR2L,
TRA2B,
SNRPN,
YBX1,
HNRNPU,
SRSF2,
SRSF11,
SRSF1,
NCBP1,
CPSF1,
SF3A3,
CSTF3,
SRSF9,
SRSF5,
SRSF6,
PRPF4B,
TRA2A,
HNRNPD,
SART3,
NONO,
RNPS1,
PCBP1,
ELAVL1,
SNRNP35,
FIP1L1,
CWC27,
DDX46,
DHX32,
PABPN1,
ALYREF,
CCAR1,
SRRM1,
ZCRB1,
GEMIN5,
SNRNP27,
PRPF31,
GEMIN6,
PSPC1,
RBPMS,
SNRNP40,
RSRC1,
RNPC3,
ZMAT2,
RBM15,
SPEN,
CDC5L,
BUD13,
HNRNPUL1,
DDX23,
SNRNP25,
SF3B5,
CRNKL1,
PNN,
DHX35,
METTL14,
CWC22,
RAVER2,
RBM22,
CWC15,
CPSF2,
LSM7,
PRPF19,
PPIE,
NOVA2,
SRRM2,
LSM2,
RBMX2,
SF3B6,
LSM5,
LSM4,
RBM8A
|
GO:0000413
|
BP
|
protein peptidyl-prolyl isomerization
|
The modification of a protein by cis-trans isomerization of a proline residue.
|
PPIH,
PPIB,
FKBP2,
PPIF,
NKTR,
PPIC,
RANBP2,
PPIA,
FKBP3,
FKBP4,
PPID,
PPIL2,
PPIG,
FKBP5,
PPP2R4,
CWC27,
PPIL4,
FKBP10,
FKBP14,
FKBP11,
PPIE,
PIN4,
FKBP7
|
GO:0000422
|
BP
|
mitophagy
|
The autophagic process in which mitochondria are delivered to the vacuole and degraded in response to changing cellular conditions.
|
PARK2,
ATG12,
GABARAPL2,
BNIP3,
SQSTM1,
WIPI1,
CISD2,
RB1CC1,
ATG2B,
FUNDC2,
PINK1,
GABARAPL1,
MAP1LC3A,
PPARGC1A,
WDR45,
WIPI2
|
GO:0000430
|
BP
|
regulation of transcription from RNA polymerase II promoter by glucose
|
Any process involving glucose that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
USF2
|
GO:0000432
|
BP
|
positive regulation of transcription from RNA polymerase II promoter by glucose
|
Any process involving glucose that activates or increases the rate of transcription from an RNA polymerase II promoter.
|
USF2
|
GO:0000435
|
BP
|
positive regulation of transcription from RNA polymerase II promoter by galactose
|
Any process involving galactose that activates or increases the rate of transcription from an RNA polymerase II promoter.
|
NCOA1
|
GO:0000447
|
BP
|
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
Endonucleolytic cleavage between the SSU-rRNA and the 5.8S rRNA of an rRNA molecule originally produced as a tricistronic rRNA transcript that contained the Small SubUnit (SSU) rRNA, the 5.8S rRNA, and the Large SubUnit (LSU) rRNA, in that order, from 5' to 3' along the primary transcript.
|
UTP20,
RPSA,
RPS21,
RRS1,
RCL1,
FCF1
|
GO:0000448
|
BP
|
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
Endonucleolytic cleavage within ITS2 between the 5.8S rRNA and the LSU-rRNA of an rRNA molecule originally produced as a tricistronic rRNA transcript that contained the Small SubUnit (SSU) rRNA, the 5.8S rRNA, and the Large SubUnit (LSU) rRNA, in that order, from 5' to 3' along the primary transcript.
|
BOP1
|
GO:0000453
|
BP
|
enzyme-directed rRNA 2'-O-methylation
|
The addition of methyl groups to the 2'-oxygen atom of nucleotide residues in an rRNA molecule during ribosome biogenesis where the methylase specifies the site that becomes methylated without using a guide RNA.
|
MRM1
|
GO:0000454
|
BP
|
snoRNA guided rRNA pseudouridine synthesis
|
The intramolecular conversion of uridine to pseudouridine in an rRNA molecule during ribosome biogenesis using a snoRNA guide that targets the position of pseudouridylation.
|
NOP10,
GAR1
|
GO:0000460
|
BP
|
maturation of 5.8S rRNA
|
Any process involved in the maturation of a precursor 5.8S ribosomal RNA (rRNA) molecule into a mature 5.8S rRNA molecule.
|
NSA2,
SKIV2L2,
EIF6,
C1D,
EXOSC4,
WDR37,
LAS1L
|
GO:0000461
|
BP
|
endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
Endonucleolytic cleavage at the 3'-end of the SSU-rRNA from an originally tricistronic rRNA transcript that contained the Small Subunit (SSU) rRNA, the 5.8S rRNA, and the Large Subunit (LSU) rRNA in that order from 5' to 3' along the primary transcript, to produce the mature end of the SSU-rRNA.
|
RPSA,
RPS21
|
GO:0000462
|
BP
|
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
Any process involved in the maturation of a precursor Small SubUnit (SSU) ribosomal RNA (rRNA) molecule into a mature SSU-rRNA molecule from the pre-rRNA molecule originally produced as a tricistronic rRNA transcript that contains the Small Subunit (SSU) rRNA, 5.8S rRNA, and the Large Subunit (LSU) in that order from 5' to 3' along the primary transcript.
|
UTP20,
RPS8,
RPS16,
RPS14,
TBL3,
TSR1,
NGDN,
EMG1,
UTP23,
DCAF13,
CCDC59,
WDR3,
FCF1,
UTP18
|
GO:0000463
|
BP
|
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
Any process involved in the maturation of a precursor Large SubUnit (LSU) ribosomal RNA (rRNA) molecule into a mature LSU-rRNA molecule from the pre-rRNA molecule originally produced as a tricistronic rRNA transcript that contains the Small Subunit (SSU) rRNA, 5.8S rRNA, and Large Subunit (LSU) in that order from 5' to 3' along the primary transcript.
|
RPL7,
RPL35,
BOP1,
WDR12
|
GO:0000466
|
BP
|
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
Any process involved in the maturation of an rRNA molecule originally produced as part of a tricistronic rRNA transcript that contained the Small SubUnit (SSU) rRNA, the 5.8S rRNA, and the Large SubUnit (LSU) rRNA, in that order, from 5' to 3' along the primary transcript.
|
WDR12
|
GO:0000467
|
BP
|
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
Exonucleolytic digestion of a pre-rRNA molecule to generate the mature 3'-end of a 5.8S rRNA molecule derived from an originally tricistronic pre-rRNA transcript that contained the Small Subunit (SSU) rRNA, the 5.8S rRNA, and the Large Subunit (LSU) rRNA in that order from 5' to 3' along the primary transcript.
|
ERI2,
ERI3,
EXOSC9,
EXOSC2,
EXOSC7,
EXOSC8,
EXOSC3
|
GO:0000469
|
BP
|
cleavage involved in rRNA processing
|
Any phosphodiester bond hydrolysis involved in the conversion of a primary ribosomal RNA (rRNA) transcript into a mature rRNA molecule.
|
NOB1
|
GO:0000470
|
BP
|
maturation of LSU-rRNA
|
Any process involved in the maturation of a precursor Large SubUnit (LSU) ribosomal RNA (rRNA) molecule into a mature LSU-rRNA molecule.
|
RSL1D1,
NSA2,
NOP2,
SNU13,
EIF6,
RPL7A,
RPL10A,
MRPL1,
WDR37,
LAS1L
|
GO:0000472
|
BP
|
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
Endonucleolytic cleavage between the 5'-External Transcribed Spacer (5'-ETS) and the 5' end of the SSU-rRNA of a tricistronic rRNA transcript that contains the Small Subunit (SSU) rRNA, the 5.8S rRNA, and the Large Subunit (LSU) rRNA in that order from 5' to 3' along the primary transcript, to produce the mature end of the SSU-rRNA.
|
UTP20
|
GO:0000478
|
BP
|
endonucleolytic cleavage involved in rRNA processing
|
Any endonucleolytic cleavage involved in the conversion of a primary ribosomal RNA (rRNA) transcript into a mature rRNA molecule. Some endonucleolytic cleavages produce the mature end, while others are a step in the process of generating the mature end from the pre-rRNA.
|
LAS1L
|
GO:0000479
|
BP
|
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
Endonucleolytic cleavage of a pre-rRNA molecule originally produced as a tricistronic rRNA transcript that contains the Small SubUnit (SSU) rRNA, the 5.8S rRNA, and the Large SubUnit (LSU) rRNA, in that order, from 5' to 3' along the primary transcript. Primary ribosomal RNA transcripts with three genes, in this order, are produced in the nuclei of many eukaryotic species, including S. cerevisiae.
|
TSR1
|
GO:0000480
|
BP
|
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
Endonucleolytic cleavage within the 5'-External Transcribed Spacer (ETS) of a tricistronic rRNA transcript that contains the Small Subunit (SSU) rRNA, the 5.8S rRNA, and the Large Subunit (LSU) rRNA in that order from 5' to 3' along the primary transcript. Endonucleolytic cleavage within the 5'-ETS of the pre-RNA is conserved as one of the early steps of rRNA processing in all eukaryotes, but the specific position of cleavage is variable.
|
UTP20,
UTP23,
RCL1,
FCF1
|
GO:0000492
|
BP
|
box C/D snoRNP assembly
|
The aggregation, arrangement and bonding together of proteins and a box C/D snoRNA to form a box C/D small nucleolar ribonucleoprotein (snoRNP) complex.
|
NUFIP1,
RUVBL2,
RUVBL1
|
GO:0000495
|
BP
|
box H/ACA snoRNA 3'-end processing
|
Any process involved in forming the mature 3' end of a box H/ACA snoRNA molecule.
|
DKC1
|
GO:0000578
|
BP
|
embryonic axis specification
|
The establishment, maintenance and elaboration of a pattern along a line or a point in an embryo.
|
COBL,
CTNNB1,
STIL,
CITED1
|
GO:0000707
|
BP
|
meiotic DNA recombinase assembly
|
During meiosis, the aggregation, arrangement and bonding together of strand exchange proteins (recombinases) to form higher order oligomers on single-stranded DNA.
|
RAD51D
|